Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

Article explains discrepancies between positive findings from 2 French studies and negative recommendations from Surviving Sepsis Campaign guidelines, and considers how antimalarial drugs be used in clinical management of patients in the ICU with severe COVID-19.


The Lancet Respiratory Medicine